Professor Mohamed El-Tanani from the Ahliyya Amman University (Jordan) with collaboration with University of Bradford’s -Institute for Cancer Therapeutics (UK), Tanta University (EGYPT) and Ulster University (UK) has also developed a way of delivering the drug directly to the cancer cells and overcome the tumour chemotherapy toxicity and resistance.
Laboratory tests have shown when the drug is added to hard-to-treat breast cancer cells, the cells actively take it in, sensitize the tumour to low dose of chemotherapy and reduced their growth rate by 98%.
The drug is a peptide, a fragment of a protein, which Prof El-Tanani found out is able to...